Track topics on Twitter Track topics that are important to you
Less than a year after coming out of stealth mode with a $65 million first-round last year, artificial intelligence specialist Insitro has already signed its first biopharma partner. The South San Francisco company has enticed Gilead with its visi...
Original Article: AI firm Insitro signs Gilead as first pharma partner with NASH dealNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...